Four common fitness and health claims that don't hold up

A single headline can travel much further than the study behind it. In a recent Q&A episode, the Barbell Medicine Podcast worked through four claims that keep circulating online: that lifting past one hour a week stops helping you live longer, that GLP-1 medications flatten your mood, that high-protein and keto diets let you eat more and still lose weight, and what training should look like with chronic fatigue syndrome.

Does lifting past an hour a week stop helping your lifespan?

A 2022 paper pooling 16 cohort studies found that the mortality benefit of strength training leveled off around 60 minutes a week, which got reported as proof that more lifting stops helping. The actual data tell a messier story. Almost nobody in that dataset trained at high volumes, training was only self-reported once at the start, and the benefit never reversed into harm, it simply stopped climbing as fast. A newer, larger Harvard study that re-measured training over time, rather than asking once, found the benefit continuing up to two hours a week. The bigger problem with both studies is the metric itself: knowing someone trained for 60 minutes says nothing about intensity, program quality, or whether they actually got stronger, which is what tracks with health outcomes. The practical takeaway holds regardless: any strength training beats none, and there is no evidence that higher training volumes shorten your life.

Do GLP-1 medications flatten your mood and motivation?

This is a common concern, and the reassuring data comes from the STEP trials, the best controlled evidence available: depression scores were slightly better on semaglutide than placebo, not worse. A suicidal ideation warning that circulated in preliminary reports was walked back in early 2026 after regulators reviewed 91 placebo-controlled trials covering roughly 108,000 patients plus more than 2 million real-world users. Blunted motivation or reduced enjoyment does happen in a minority of patients, more often at the highest doses and more often with tirzepatide than semaglutide, but it is reversible: lowering the dose or adding a medication like bupropion typically resolves it. Libido concerns tend to go the other direction: since excess body fat lowers testosterone, and these medications reduce that fat, testosterone and libido often improve rather than decline, though rapid weight loss and reduced eating can temporarily mask that benefit with fatigue. The bigger safety concern is sourcing GLP-1s through unregulated gray-market peptides, where dosing and purity cannot be verified at all.

Why "eating more and still losing weight" isn't breaking physics

A calorie is simply a unit of energy, so yes, a calorie is a calorie, but that framing is not useful advice on its own, since both sides of the energy balance equation shift constantly. In one commonly cited high-protein trial, participants prescribed the same calorie target as a standard-protein group ended up eating 90 to 130 fewer calories a day on their own, mainly because added protein displaced other higher-calorie foods. The same pattern explains keto's apparent magic: people report eating more and still losing weight, but when actual intake is measured, it consistently drops, and keto's short-term edge disappears by six to twelve months compared to other diets. Neither approach breaks the rules of energy balance; both just change what people choose to eat.

Training with chronic fatigue syndrome

Chronic fatigue syndrome, also called ME/CFS, is a real, formally diagnosable condition, and its defining feature is post-exertional malaise: a delayed crash lasting days, disproportionate to the effort involved, not ordinary next-day soreness. Twin studies confirm this is physiological, not motivational, showing a measurable drop in exercise capacity on a second test day in the twin with the condition but not the healthy one. The old approach of gradually pushing patients to do more, called graded exercise, has been walked back because it tends to make people worse. Current, more cautious guidance favors shorter sessions with fewer exercises, longer rest periods, lower effort targets (aiming for a 5 or 6 out of 10 rather than pushing to 7 or 8), and double progression, adding weight only once every set comfortably hits the top of a rep range. Isometric holds work as a lower-demand backup on the worst days, and lifting weights while lying in bed, while not a full training session, still counts as more than doing nothing. Just as important: track how someone feels two and three days later, not only immediately after training, since the crash is often delayed and easy to miss if you only check in right after the session.

The bottom line

All four claims share the same flaw: a single number, whether it's minutes trained, a drug class, or a macronutrient percentage, gets treated as the whole story. The more useful question is always what actually changed for the person doing it, their strength, their symptoms, their daily intake, since that is what the outcomes actually track.